Hints and tips:
...Jeffrey Holford, analyst at Jefferies, acknowledged the cut in long-term guidance would be viewed negatively but noted the revised targets were roughly in line with existing market consensus....
...Jeffrey Holford, analyst at Jefferies, said the declining price of Lantus would drag down the whole insulin market and warned that “Novo Nordisk may be the worst impacted due to its higher dependence on...
...“Insulin is a high-volume, low-cost drug,” says Lars Sorensen, chief executive of Novo Nordisk....
...Holden, Leeds Russell Wheeler, Winchester, Hants Ojay McDonald, Manchester Jonathan Scott-Lee, London Rolfe Lakin, Colchester Christian Armstrong, Glasgow, Scotland Seb Beloe, London Dr Carsten Sorensen...
International Edition